Management of metformin-associated lactic acidosis by continuous renal replacement therapy.
<h4>Background</h4>Metformin-associated lactic acidosis (MALA) is a severe metabolic failure with high related mortality. Although its use is controversial, intermittent hemodialysis is reported to be the most frequently used treatment in conjunction with nonspecific supportive measures....
Guardado en:
Autores principales: | Geoffray Keller, Martin Cour, Romain Hernu, Julien Illinger, Dominique Robert, Laurent Argaud |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0cf870f870b4bf986fa9fbd73824489 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Continuous Renal Replacement Therapy for Two Neonates With Hyperammonemia
por: Christopher Markham, et al.
Publicado: (2021) -
Machine learning model to predict hypotension after starting continuous renal replacement therapy
por: Min Woo Kang, et al.
Publicado: (2021) -
Lessons Learned from a Small Pediatric Continuous Renal Replacement Therapy Program
por: Tanya Holt, et al.
Publicado: (2021) -
Differential metabolic responses in breast cancer cell lines to acidosis and lactic acidosis revealed by stable isotope assisted metabolomics
por: Jiayue Gao, et al.
Publicado: (2020) -
Focal brain lactate accumulation in metformin-induced encephalopathy without systemic lactic acidosis: A case report suggesting mitochondrial vulnerability in lentiform fork sign
por: Akira Hanazono, et al.
Publicado: (2021)